DR. PETER CLOWES DOWLING, M.D.
Neurology at Tremont Ave, East Orange, NJ
License number
New Jersey 25MA02695600
Category
Neurology
Type
Neurology
Address
Address
2
385 Tremont Ave, East Orange, NJ 07018
4 Horizon Rd, West Fort Lee, NJ 07024
4 Horizon Rd, West Fort Lee, NJ 07024
Phone
(973) 676-1000
(201) 224-6627
(201) 224-6627
Personal information
See more information about PETER CLOWES DOWLING at radaris.comName
Address
Phone
4 Horizon Rd APT 620, Fort Lee, NJ 07024
81 Abbotsford Rd, North Plainfield, NJ 07062
1 Claremont Dr, Maplewood, NJ 07040
14 Essex Pl, Basking Ridge, NJ 07946
14 Essex, Millington, NJ 07946
Professional information
Peter Clowes Dowling, East Orange NJ
Specialties:
Neurologist
Address:
385 Tremont Ave, East Orange, NJ 07018
Education:
University of Vermont, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Dr. Peter C Dowling, East Orange NJ - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
385 Tremont Ave SUITE 7, East Orange 07018
(973) 676-1000 (Phone)
(973) 676-1000 (Phone)
Certifications:
Neurology, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Vermont / College of Medicine
Graduated: 1963
University of Vermont / College of Medicine
Graduated: 1963
Methods For Treating Inflammatory Disorders And Traumatic Brain Injury Using Stabilized Non-Hematopoietic Epo Short Peptides
US Patent:
2011019, Aug 4, 2011
Filed:
Mar 28, 2011
Appl. No.:
13/073275
Inventors:
Bo Wang - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US
Peter C. Dowling - Fort Lee NJ, US
Rui Rong Yuan - Fort Lee NJ, US
Wei Lu - Harrison NJ, US
Peter C. Dowling - Fort Lee NJ, US
International Classification:
A61K 38/12, A61P 29/00, A61P 25/00, A61P 25/28, A61P 25/16, A61P 27/02, A61P 27/00, A61P 27/16
US Classification:
514 178, 514 177, 514 179
Abstract:
The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an inflammatory component in a subject in need thereof using isolated erythropoietin (EPO)-derived oligopeptides.
Erythropoietin-Derived Short Peptide And Its Mimics As Immuno/Inflammatory Modulators
US Patent:
2009002, Jan 29, 2009
Filed:
May 1, 2006
Appl. No.:
11/913038
Inventors:
Rui Rong Yuan - Fort Lee NJ, US
Wei Ping Li - Kearny NJ, US
Joseph Menonna - Dumont NJ, US
Yasuhiro Maeda - Belle Mead NJ, US
Peter Dowling - Fort Lee NJ, US
Wei Ping Li - Kearny NJ, US
Joseph Menonna - Dumont NJ, US
Yasuhiro Maeda - Belle Mead NJ, US
Peter Dowling - Fort Lee NJ, US
Assignee:
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY - Newark NJ
International Classification:
C07K 14/575, C07K 9/00, A61K 38/22, A61K 38/14, A61P 29/00, A61P 37/00
US Classification:
514 8, 530397, 530322
Abstract:
The present invention provides isolated stabilized EPO-derived peptides and their mimics that protect against tissue damage in subjects having diverse forms of neural and non-neural organ system injury, pharmaceutical compositions containing the isolated stabilized EPO-derived peptides, methods for treating symptoms of a disease, disorder or condition having an inflammatory or an autoimmune component in a subject in need thereof, and methods for downregulating immune mediator activity in a subject in need thereof.